ASX/LTP (ASX/LTP)

Australian Securities Exchange: ASX/LTP · AUD

A$0.43

-0.01 (-1.1%)· Recorded snapshot

Market cap	78.4M
Revenue (ttm)	723.9K
Net income (ttm)	-14.2M
EPS (ttm)	-A$0.08
Shares out	182.3M
Volume	27,545
Beta	2.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 723.9K
Net income (ttm): -14.2M
EPS (ttm): -A$0.08
Market cap: 78.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-54.7

P25 n/aP50 n/aP75 n/a

ROIC-33.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/LTP indicators

Market & fundamental data

Available fields

153

Groups with data

Currency

AUD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-09-11
Enterprise value	AUD 58.7M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2020
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000305294
Last earnings date	2026-02-26
Last refreshed	2026-10-30
Market cap	AUD 78.4M
Price	AUD 0.43
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	asx/LTP
Website	https://ltrpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-18.15%
EV/Sales	81.11x
FCF / EV yield	-18.47%
FCF yield	-13.84%
Industry forward P/E	28.82x
P/B ratio	3.87x
P/S ratio	108.27x
Price / tangible book value	3.87x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-1,932.77%
Pretax margin	-1,956.57%
ROA	-32.96%
ROA (5Y)	-60.44%
ROCE	-69.09%
ROE	-54.73%
ROE (5Y)	-111.85%
ROIC	-33.79%
SBC / revenue	423.93%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	-52.01%
Revenue growth (Q)	-38.53%
Revenue growth (QoQ)	781.66%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -5,946
Depreciation and amortization	AUD 5,772
EBIT	AUD -14M
EBITDA	AUD -14M
EPS	AUD -0.08
FCF per share	AUD -0.06
Free cash flow	AUD -10.8M
Free cash flow minus SBC	AUD -13.9M
Gross profit	AUD -6M
Investing cash flow	AUD -1.1M
Net cash flow	AUD -12.1M
Net income	AUD -14.2M
Operating cash flow minus SBC	AUD -13.9M
Operating income	AUD -14M
Revenue	AUD 723,935
Stock-based compensation	AUD 3.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	83.69
Book value per share	AUD 0.11
Debt / equity	0
Interest coverage	-40,091.64
Long-term assets	AUD 184,845
Long-term liabilities	AUD 0
Net cash (debt)	AUD 19.7M
Net cash / market cap	25.09%
Net cash growth	-38.19%
Net debt / equity	-0.97
Piotroski F-Score	1
Property, plant and equipment	AUD 12,778
Shareholders' equity	AUD 20.3M
Tangible book value	AUD 20.3M
Tangible book value per share	AUD 0.11
Total assets	AUD 20.9M
Total cash	AUD 19.7M
Total debt	AUD 0
Total liabilities	AUD 601,490
WACC	16.34%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	AUD 20.7M
Current liabilities	AUD 601,490
Current ratio	34.36
Inventory turnover	22.87
Net working capital	AUD 403,584
Quick ratio	33.1
Working capital	AUD 20.1M
Working capital turnover	0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.54%
Shareholder yield	-8.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.46
1D price change	-1.15%
1M price change	-10.42%
1M total return	-10.42%
1W price change	-3.37%
1W total return	-3.37%
1Y price change	-10.42%
1Y return CAGR	-10.42%
1Y total return	-10.42%
20-day SMA	AUD 0.47
200-day SMA	AUD 0.47
3M price change	-5.49%
3M total return	-5.49%
50-day SMA	AUD 0.47
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.75
52-week high date	2026-01-02
52-week low	AUD 0.35
52-week low date	2026-05-26
6M price change	6.17%
6M total return	6.17%
All-time high	AUD 2.15
All-time high date	2024-10-09
All-time low	AUD 0.24
All-time low date	2024-05-01
Average true range (ATR)	AUD 0.02
Average volume	154.8K
Beta (1Y)	0.83
Beta (2Y)	1.59
Beta (5Y)	2.2
Change from 52-week high	-42.67%
Change from 52-week low	22.86%
Change from all-time high	-80%
Change from all-time low	82.98%
Change from open	-1.15%
Day's gap	0%
Dollar volume	AUD 11,844
High price	AUD 0.44
Low price	AUD 0.43
Monthly RSI	48.1
Open price	AUD 0.44
Position in 52-week range	0%
Previous close	AUD 0.44
Price vs 150-day SMA	-7.47%
Price vs 20-day SMA	-7.57%
Price vs 200-day SMA	-8.49%
Price vs 50-day SMA	-8.47%
Relative volume	0.18
RSI	38.74
Sharpe ratio	0.16
Sortino ratio	0.38
Volume	27.5K
Weekly RSI	43.98
YTD price change	-40.28%
YTD total return	-40.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	107.1M
Shares change (QoQ)	0.4%
Shares change (YoY)	8.54%
Shares held by insiders	5.4%
Shares held by institutions	0.7%
Shares outstanding	182.3M

Deeper analysis on ASX/LTP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/LTP report

Is a complete ASX/LTP research report available?

No complete published report is available for asx/LTP (ASX/LTP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/LTP (ASX/LTP)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/LTP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/LTP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/LTP

Frequently asked questions